These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 22076425

  • 1. Epigenetic alterations in sperm DNA associated with testicular cancer treatment.
    Chan D, Delbès G, Landry M, Robaire B, Trasler JM.
    Toxicol Sci; 2012 Feb; 125(2):532-43. PubMed ID: 22076425
    [Abstract] [Full Text] [Related]

  • 2. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.
    Delbès G, Chan D, Pakarinen P, Trasler JM, Hales BF, Robaire B.
    Biol Reprod; 2009 Feb; 80(2):320-7. PubMed ID: 18987330
    [Abstract] [Full Text] [Related]

  • 3. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat.
    Marcon L, Hales BF, Robaire B.
    J Androl; 2008 Feb; 29(4):408-17. PubMed ID: 18296477
    [Abstract] [Full Text] [Related]

  • 4. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility.
    Bieber AM, Marcon L, Hales BF, Robaire B.
    J Androl; 2006 Feb; 27(2):189-200. PubMed ID: 16278370
    [Abstract] [Full Text] [Related]

  • 5. Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity.
    Delbes G, Hales BF, Robaire B.
    J Androl; 2007 Feb; 28(2):241-9; discussion 250-1. PubMed ID: 17021337
    [Abstract] [Full Text] [Related]

  • 6. Effects of chemotherapeutic agents for testicular cancer on rat spermatogonial stem/progenitor cells.
    Marcon L, Zhang X, Hales BF, Robaire B, Nagano MC.
    J Androl; 2011 Feb; 32(4):432-43. PubMed ID: 21088230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective induction of glutathione S-transferases in round spermatids from the Brown-Norway rat by the chemotherapeutic regimen for testicular cancer.
    Delbès G, Chan D, Hales BF, Trasler JM, Robaire B.
    Reprod Toxicol; 2013 Apr; 36():24-32. PubMed ID: 23200778
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epigenetics in spermatogenesis.
    Trasler JM.
    Mol Cell Endocrinol; 2009 Jul 10; 306(1-2):33-6. PubMed ID: 19481683
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects of 5-aza-2'-deoxycytidine on spermatogenesis include reduced sperm function and selective inhibition of de novo DNA methylation.
    Oakes CC, Kelly TL, Robaire B, Trasler JM.
    J Pharmacol Exp Ther; 2007 Sep 10; 322(3):1171-80. PubMed ID: 17581917
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of zinc on rat sperm chromatin integrity involvement: DNA methylation, DNA fragmentation, ubiquitination and protamination after bleomycin etoposide and cis-platin treatment.
    Khadivi F, Razavi S, Hashemi F.
    Theriogenology; 2020 Jan 15; 142():177-183. PubMed ID: 31600638
    [Abstract] [Full Text] [Related]

  • 14. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP.
    J Urol; 1997 Mar 15; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP, Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    J Clin Oncol; 2008 Jan 20; 26(3):421-7. PubMed ID: 18202419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 18. Regeneration of spermatogenesis after testicular cancer chemotherapy.
    Suzuki K, Yumura Y, Ogawa T, Saito K, Kinoshita Y, Noguchi K.
    Urol Int; 2013 Jul 01; 91(4):445-50. PubMed ID: 24021744
    [Abstract] [Full Text] [Related]

  • 19. Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats.
    Kilarkaje N, Mousa AM, Al-Bader MM, Khan KM.
    Fertil Steril; 2013 Oct 01; 100(4):1151-9. PubMed ID: 23850298
    [Abstract] [Full Text] [Related]

  • 20. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.
    Semin Oncol; 1998 Apr 01; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.